Biomarkers of response to antibody-drug conjugates (TROP2 and nectin-4) and the immune microenvironment (NKG7, PD-L1, and B7-H3) in penile squamous cell carcinoma
American Journal of Clinical Pathology · 2025
DOI: 10.1093/ajcp/aqaf022 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2025. Verfasst von Burak Tekin und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Tumor Microenvironment, Biomarkers, Tumor, Cell Adhesion Molecules. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Objectives
We aimed to assess the expression of biomarkers of response to antibody-drug conjugates (TROP2 and nectin-4) and immune microenvironment (NKG7, PD-L1, and B7-H3) in penile squamous cell carcinoma (pSCC).
Methods
Our archive was queried for patients who had a penectomy for pSCC between 2000 and 2022. Primary tumors were immunostained for B7-H3 and NKG7, while metastatic specimens were immunostained for TROP2 and nectin-4. Expression of PD-L1, TROP2, and nectin-4 in primary tumors was previously characterized. H-scores (0-300) were used to quantify expression. Associations between biomarkers, tumor-infiltrating lymphocytes (TILs), and clinicopathologic and outcome parameters were evaluated.
Results
For both TROP2 and nectin-4, H-scores within the lymph node metastases were higher compared to those within the primary tumors (mean, 264.5 vs 244.8, P = .0003; mean, 170.6 vs 146.7, P = .05, respectively; 33 paired specimens). For B7-H3 (n = 107), 32.7% of the primary tumors had an H-score of more than 0. In 34.8% of the cases, NKG7 expression was observed in 25% to 50% of the TILs. A significant association was noted between TIL density, B7-H3, NKG7, and PD-L1 expression.
Conclusions
Therapeutic strategies targeting TROP2 and nectin-4 hold promise for patients with advanced pSCC. The potential of PD-L1, B7-H3, and NKG7 for predicting response to immunomodulatory treatment warrants further research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
- Department of Urology, Mayo Clinic, Rochester, MN, United States.
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States.
- Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
- Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, United States.
ORCID-Profile: Fabrice Lucien, Carin Y Smith
Zitieren
APA
Tekin, B., Cheville, J. C., Lucien, F., McCarthy, M., Dong, H., Kopp, K. J., Torell, N. R., Lavoie, R. R., Farrell, A., Jaszewski, B. L., Smith, C. Y., Jenkins, S. M., Dasari, S., Menon, S., Whaley, R. D., Boorjian, S. A., Pagliaro, L. C., Erickson, L. A., Guo, R., & Gupta, S. (2025). Biomarkers of response to antibody-drug conjugates (TROP2 and nectin-4) and the immune microenvironment (NKG7, PD-L1, and B7-H3) in penile squamous cell carcinoma. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqaf022
Vancouver
Tekin B, Cheville JC, Lucien F, McCarthy M, Dong H, Kopp KJ, et al. Biomarkers of response to antibody-drug conjugates (TROP2 and nectin-4) and the immune microenvironment (NKG7, PD-L1, and B7-H3) in penile squamous cell carcinoma. American Journal of Clinical Pathology. 2025. doi:10.1093/ajcp/aqaf022
BibTeX
@article{Tekin2025,
author = {Tekin, Burak and Cheville, John C and Lucien, Fabrice and McCarthy, Michael and Dong, Haidong and Kopp, Karla J and Torell, Nate R and Lavoie, Roxane R and Farrell, Ava and Jaszewski, Brandy L and Smith, Carin Y and Jenkins, Sarah M and Dasari, Surendra and Menon, Santosh and Whaley, Rumeal D and Boorjian, Stephen A and Pagliaro, Lance C and Erickson, Lori A and Guo, Ruifeng and Gupta, Sounak},
title = {Biomarkers of response to antibody-drug conjugates (TROP2 and nectin-4) and the immune microenvironment (NKG7, PD-L1, and B7-H3) in penile squamous cell carcinoma},
journal = {American Journal of Clinical Pathology},
year = {2025},
doi = {10.1093/ajcp/aqaf022}
}
EUVIMED